Portfolio company
BlossomHill Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biopharmaceutical company
This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.
SFA Theraputics
This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.
HotSpot Therapeutics
The company develops allosteric small molecule medicines for patients with cancer and autoimmune diseases by targeting natural regulatory pockets on proteins.
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
Hillstar Bio
This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.
Allorion
This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.
Graviton Bioscience Corporation
The company develops small-molecule therapeutics targeting autoimmune, fibrotic and central nervous system diseases for patients with unmet medical needs.